Rani Therapeutics logo

Rani Therapeutics

A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies

7

Funding Rounds

$529.0m

Money raised

Overview

A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies

Funding

Funding series

Funding Series Analysis

The company Rani Therapeutics has raised a total of $332m in funding over 7 rounds.

Key Insights:

  • Rani Therapeutics Venture round: $220m
  • Rani Therapeutics Initial public offering (IPO): $73m
  • Rani Therapeutics Series D round, September 2017: $39m
  • Rani Therapeutics funding round, February 2018: $53m
  • Rani Therapeutics, LLC funding round, November 2020: $75m
  • Rani Therapeutics Series E round December 2020: $69m
Rani Therapeutics logo
Rani Therapeutics Venture round $220m
Rani Therapeutics logo
Rani Therapeutics Initial public offering (IPO) $73m
Rani Therapeutics logo
Rani Therapeutics Series D round, September 2017 $39m
Rani Therapeutics logo
Rani Therapeutics funding round, February 2018 $53m
Rani Therapeutics logo
Rani Therapeutics, LLC funding round, November 2020 $75m
Rani Therapeutics logo
Rani Therapeutics Series E round December 2020 $69m

Industries

Rani Therapeutics is active in the following industries:
  • Therapeutics
  • Drug delivery
  • Therapy
  • Biomedical engineering
  • Speciality chemicals
  • Engineering
  • Technology
  • Biology
  • Biotechnology
  • Healthcare
  • Biosimilar